The presentation of multisystem inflammatory syndrome varies in adults


Patients with multisystem inflammatory syndrome in adults (MIS-A) after severe infection with acute respiratory syndrome by coronavirus 2 (SARS-CoV-2) have a heterogeneous clinical presentation, according to a research letter published online on 19 May a JAMA network open.

Giovanni E. Davogustto, MD, of Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues conducted a single-center study to describe the spectrum of MIS-A presentation after SARS infection -CoV-2. Of the 839 patients admitted with a positive SARS-CoV-2 test result, 156 were classified as at risk for MIS-A, and of these patients, 15 met the MIS-A criteria.

The researchers found that patients with MIS-A were younger than those admitted for acute symptoms of COVD-19 (, 45.1 versus 56.5 years) and were more likely to have evidence of SARS-CoV-2 infection documented by serological testing (60.0 percent versus no patient). Nine of the 15 patients (60.0 percent) with MIS-A had acute symptoms of COVID-19 and 20.0 percent required admission for acute COVID-19 prior to admission to MIS-A. During MIS-A admission, 33.3 percent of patients required intensive care treatment for hemodynamic follow-up, vasopressor support, or noninvasive ventilatory support (three, one, and one patient, respectively). Three (20.0 percent) had MIS-A as a during admission to MIS-A; 26.7 and 46.6 percent received immunosuppressive and antibiotic therapy, respectively. There were no deaths. An average of four were involved, the most affected being the gastrointestinal, hematological and renal systems.

“These data suggest that, although uncommon, MIS-A has a more heterogeneous clinical presentation than previously seen and is often underdiagnosed,” the authors write.

One author revealed links to the pharmaceutical industry.

Low risk of serious side effects after SARS-CoV-2 without hospitalization

More information:
Giovanni E. Davogustto et al, Characteristics associated with multisystem inflammatory syndrome among adults with SARS-CoV-2 infection, JAMA network open (2021). DOI: 10.1001 / jamanetworkopen.2021.10323

© 2021 HealthDay. All rights reserved.

Citation: The presentation of multisystem inflammatory syndrome varies in adults (2021, May 20) retrieved May 20, 2021 at html

This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.

Source link